|
Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, Pena-Pena ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Hegde SM, Lakdawala NK, Lewis GD, Mann A, Miao ZM, Nair A, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA; MAPLE-HCM Investigators. Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2025 Sep 11;393(10):949-960. doi: 10.1056/NEJMoa2504654. Epub 2025 Aug 30. PubMed PMID: 40888697.
AÑO: 2025; IF: 78.5
|
40888697
|
Larranaga-Moreira JM, Ochoa JP, Peteiro-Deben R, Martin-Alvarez E, Ripoll-Vera T, Alvarez-Rubio J, Pena-Pena ML, Llamas-Gomez H, Fernandez A, Gallego-Delgado M, Rodriguez-Serrano AI, Diez-Lopez C, Elliott PM, Palomino-Doza J, Lorca R, Limeres J, Azevedo O, Zorio E, Martin-Dorado E, Mendez-Fernandez I, Franco-Gutierrez R, de Frutos F, Escudero A, Ruiz-Guerrero L, Rodriguez-Vilela A, Mazzanti A, McKenna WJ, Barriales-Villa R; TNN Investigators. The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy. JACC Heart Fail. 2025 Apr 30:102419. doi: 10.1016/j.jchf.2025.01.024. Online ahead of print. PubMed PMID: 40310325.
AÑO: 2025; IF: 11.8
|
|
van der Heide MYC, Verstraelen TE, de Brouwer R, van Drie E, Proost VM, van Lint FHM, Bosman LP, Houweling AC, Dickhoff C, Germans T, Schoonderwoerd BA, Gimeno-Blanes JR, Meems LMG, Te Riele ASJM, van Spaendonck-Zwarts KY, Cox MGPJ, Amin AS, van Tintelen JP, de Boer RA, Zwinderman AH, Wilde AAM. Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive Individuals. JACC Heart Fail. 2025 Oct;13(10):102558. doi: 10.1016/j.jchf.2025.102558. Epub 2025 Aug 9. PubMed PMID: 40782726.
AÑO: 2025; IF: 11.8
|
|
Protonotarios A, Asimaki A, Basso C, Xylouri Z, Monda E, Protonotarios I, Crisci G, Abrahms DJ, Anastasakis A, Antoniades L, Bakalakos A, Carbone A, S Coonar A, Gimeno JR, Lazaros G, Lerakis S, Mestroni L, Papadopoulos G, Pecchia L, Prandi FR, Syrris P, Cadrin-Turigny J, Vasilakis A, Saffitz JE, Gaetano Thiene S, Elliott PM, Kaski JP, McKenna WJ, Bossone E, Limongelli G, Tsatsopoulou A. Naxos Disease and Related Cardio-Cutaneous Syndromes. JACC Adv. 2025 Jan 10;4(2):101547. doi: 10.1016/j.jacadv.2024.101547. eCollection 2025 Feb. PubMed PMID: 39877668; PubMed Central PMCID: PMC11773020.
AÑO: 2025
|
|
Fernandez Gil MJ, Carrillo Mora LM, Fernandez Vazquez D, Melgarejo F, Santos Mateo JJ, Munoz Esparza C, Rodriguez Serrano AI, Navarro-Penalver M, Sanchez Munoz JJ, Gimeno-Blanes FJ, Sabater-Molina M, Gimeno JR. Impact of physical activity on presentation and prognosis of Brugada syndrome. Open Heart. 2025 Dec 18;12(2):e003119. doi: 10.1136/openhrt-2024-003119. PubMed PMID: 41419229; PubMed Central PMCID: PMC12716582.
AÑO: 2025; IF: 2.8
|